BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of two distinguished scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD.
Related news for (BFRG)
- BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients
- Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/11/25 03:00 PM
- Today’s Top Performers: MoBot’s Market Review 04/11/25 02:00 PM
- MoBot’s Stock Market Highlights – 04/11/25 01:00 PM